Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

   
   

This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56.sup.lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.

 
Web www.patentalert.com

< Stabilized insulin formulations

< Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls

> Substituted indoles as alpha-1 agonists

> Method and composition for treating cancer using cellular organelle crystallizing agents

~ 00160